A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action

被引:51
作者
Mokaya, Jolynne [1 ]
McNaughton, Anna L. [1 ]
Hadley, Martin J. [2 ]
Beloukas, Apostolos [3 ]
Geretti, Anna-Maria [3 ]
Goedhals, Dominique [4 ]
Matthews, Philippa C. [1 ,5 ]
机构
[1] Univ Oxford, Nuffield Dept Med, Oxford, England
[2] Univ Oxford, Acad IT Dept, Oxford, England
[3] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England
[4] Univ Free State, Div Virol, Natl Hlth Lab Serv, Bloemfontein, South Africa
[5] Oxford Univ Hosp NHS Fdn Trust, Dept Microbiol & Infect Dis, John Radcliffe Hosp, Oxford, England
来源
PLOS NEGLECTED TROPICAL DISEASES | 2018年 / 12卷 / 08期
基金
英国惠康基金;
关键词
LAMIVUDINE-RESISTANT HBV; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; MOLECULAR EPIDEMIOLOGY; COINFECTED PATIENTS; PREGNANT-WOMEN; TENOFOVIR; NAIVE; PREVENTION; GENOTYPES;
D O I
10.1371/journal.pntd.0006629
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
International sustainable development goals for the elimination of viral hepatitis as a public health problem by 2030 highlight the pressing need to optimize strategies for prevention, diagnosis and treatment. Selected or transmitted resistance associated mutations (RAMs) and vaccine escape mutations (VEMs) in hepatitis B virus (HBV) may reduce the success of existing treatment and prevention strategies. These issues are particularly pertinent for many settings in Africa where there is high HBV prevalence and co-endemic HIV infection, but lack of robust epidemiological data and limited education, diagnostics and clinical care. The prevalence, distribution and impact of RAMs and VEMs in these populations are neglected in the current literature. We therefore set out to assimilate data for sub-Saharan Africa through a systematic literature review and analysis of published sequence data, and present these in an on-line database (https://livedataoxford.shinyapps.io/1510659619-3Xkoe2NKkKJ7Drg/). The majority of the data were from HIV/HBV coinfected cohorts. The commonest RAM was rtM204I/V, either alone or in combination with associated mutations, and identified in both reportedly treatment-naive and treatment-experienced adults. We also identified the suite of mutations rtM204V/I + rtL180M + rtV173L, that has been associated with vaccine escape, in over 1/3 of cohorts. Although tenofovir has a high genetic barrier to resistance, it is of concern that emerging data suggest polymorphisms that may be associated with resistance, although the precise clinical impact of these is unknown. Overall, there is an urgent need for improved diagnostic screening, enhanced laboratory assessment of HBV before and during therapy, and sustained roll out of tenofovir in preference to lamivudine alone. Further data are needed in order to inform population and individual approaches to HBV diagnosis, monitoring and therapy in these highly vulnerable settings.
引用
收藏
页数:24
相关论文
共 92 条
  • [1] Agbaji O O, 2011, West Afr J Med, V30, P164
  • [2] Evidence of susceptibility to lamivudine-based HAART and genetic stability of hepatitis B virus (HBV) in HIV co-infected patients: A South African longitudinal HBV whole genome study
    Amponsah-Dacosta, Edina
    Rakgole, J. Nare
    Gededzha, Maemu P.
    Lukhwareni, Azwidowi
    Blackard, Jason T.
    Selabe, Selokela G.
    Mphahlele, M. Jeffrey
    [J]. INFECTION GENETICS AND EVOLUTION, 2016, 43 : 232 - 238
  • [3] Hepatitis B virus infection in post-vaccination South Africa: Occult HBV infection and circulating surface gene variants
    Amponsah-Dacosta, Edina
    Lebelo, Ramokone L.
    Rakgole, J. Nare
    Selabe, Selokela G.
    Gededzha, Maemu P.
    Mayaphi, Simnikiwe H.
    Powell, Eleanor A.
    Blackard, Jason T.
    Mphahlele, M. Jeffrey
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2015, 63 : 12 - 17
  • [4] Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana
    Anderson, Motswedi
    Gaseitsiwe, Simani
    Moyo, Sikhulile
    Wessels, Matthijs J. C.
    Mohammed, Terence
    Sebunya, Theresa K.
    Powell, Eleanor A.
    Makhema, Joseph
    Blackard, Jason T.
    Marlink, Richard
    Essex, Max
    Musonda, Rosemary M.
    [J]. BMC INFECTIOUS DISEASES, 2015, 15
  • [5] The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa
    Andersson, M. I.
    Maponga, T. G.
    Ijaz, S.
    Barnes, J.
    Theron, G. B.
    Meredith, S. A.
    Preiser, W.
    Tedder, R. S.
    [J]. VACCINE, 2013, 31 (47) : 5579 - 5584
  • [6] [Anonymous], 2015, WHO HEPATITIS B TREA
  • [7] [Anonymous], 2013, WHO SURVEILLANCE TRA
  • [8] [Anonymous], 2017, ANTIMICROBIAL DRUG R
  • [9] [Anonymous], 2016, WHO | Combating hepatitis B and C to reach elimination by 2030
  • [10] [Anonymous], 2010, WHO CLIN GUIDELINES